Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 24, 2022

SELL
$72.5 - $100.68 $49,807 - $69,167
-687 Closed
0 $0
Q2 2021

Aug 12, 2021

SELL
$93.66 - $139.27 $749 - $1,114
-8 Reduced 1.15%
687 $66,000
Q1 2021

Apr 23, 2021

SELL
$116.57 - $155.01 $23,547 - $31,312
-202 Reduced 22.52%
695 $92,000
Q4 2020

Jan 28, 2021

BUY
$99.61 - $142.12 $89,350 - $127,481
897 New
897 $119,000
Q1 2020

May 11, 2020

SELL
$37.9 - $104.44 $29,713 - $81,880
-784 Closed
0 $0
Q4 2019

Feb 10, 2020

BUY
$77.66 - $99.74 $60,885 - $78,196
784 New
784 $72,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $9.61B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Fieldpoint Private Securities, LLC Portfolio

Follow Fieldpoint Private Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fieldpoint Private Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fieldpoint Private Securities, LLC with notifications on news.